SCHEMBL30364429

SCHEMBL30364429

CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)c(C)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.78
PARP2 Q9UGN5 9/20 0.78
DYRK3 O43781 1/20 0.78
TNKS O95271 1/20 0.78
PGR P06401 1/20 0.78
CDK1 P06493 1/20 0.78
ADRB1 P08588 1/20 0.78
POLA1 P09884 1/20 0.78
PIM1 P11309 1/20 0.78
SLC6A2 P23975 1/20 0.78
ADRA1A P35348 1/20 0.78
PTGS2 P35354 1/20 0.78
CDK16 Q00536 1/20 0.78
PDE4D Q08499 1/20 0.78
KCNH2 Q12809 1/20 0.78
DYRK1A Q13627 1/20 0.78
PARP15 Q460N3 1/20 0.78
PARP14 Q460N5 1/20 0.78
PARP10 Q53GL7 1/20 0.78
PIM3 Q86V86 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25149880 1.00 PARP1 (0.78) PARP1PARP2DYRK3TNKSPGR
SCHEMBL30364570 0.89 PARP1 (0.77) PARP1PARP2DYRK3TNKSPGR
SCHEMBL25150536 0.89 PARP1 (0.77) PARP1PARP2DYRK3TNKSPGR
Rucaparib SCHEMBL844585 0.88 PARP1 (1.00) PARP1PARP2DYRK3TNKSPGR
Rucaparib SCHEMBL29351768 0.88 PARP1 (1.00) PARP1PARP2DYRK3TNKSPGR
SCHEMBL30364837 0.88 PARP1 (0.74) PARP1PARP2DYRK3TNKSPGR
SCHEMBL25150519 0.88 PARP1 (0.74) PARP1PARP2DYRK3TNKSPGR
Rucaparib SCHEMBL29392034 0.87 PARP1 (0.98) PARP1PARP2DYRK3TNKSPGR
Rucaparib SCHEMBL5746065 0.87 PARP1 (0.98) PARP1PARP2DYRK3TNKSPGR
SCHEMBL5001964 0.85 PARP1 (0.80) PARP1PARP2DYRK3TNKSPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4416151-A1 CHIMERIC COMPOUNDS USEFUL IN TREATING DISEASES Padarn Therapeutics, Inc. (US) 2024-08-21 EP disclosed
WO-2023064164-A1 CHIMERIC COMPOUNDS USEFUL IN TREATING DISEASES PADARN THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed